methylprednisolone has been researched along with Uveal Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Buzaid, AC; Fernandes, Í; Schvartsman, G; Souza, IL; Taranto, P | 1 |
1 other study(ies) available for methylprednisolone and Uveal Neoplasms
Article | Year |
---|---|
Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Delayed Diagnosis; Diagnosis, Differential; Female; Glucocorticoids; Humans; Ipilimumab; Length of Stay; Liver Neoplasms; Lung; Male; Melanoma; Methylprednisolone; Nasopharynx; Neoplasms, Unknown Primary; Nivolumab; Pandemics; Pneumonia; Pneumonia, Viral; SARS-CoV-2; Time Factors; Time-to-Treatment; Tomography, X-Ray Computed; Uveal Neoplasms | 2020 |